FINDRISC diabetes risk calculator

What FINDRISC predicts

FINDRISC is a non-invasive risk score that estimates your probability of developing type 2 diabetes within the next 10 years, using 8 lifestyle and clinical questions. No blood test is required. It was developed by Lindström and Tuomilehto in the Finnish DPS cohort (2003) and has since been validated in dozens of populations across four continents.

It is endorsed by the International Diabetes Federation and forms the basis of national diabetes-prevention screening programmes in Finland, Germany, Spain, and others.

Risk bands (Lindström 2003, Table 4)

These are population averages. Individual probability is shaped by factors not in the score (genetic markers, ethnicity, gestational diabetes history, polycystic ovary syndrome, certain medications).

Why this score, not just BMI?

BMI alone misses much of the variation in diabetes risk. Two of the strongest modifiable predictors — central adiposity (waist) and physical activity — are not captured by BMI. Two of the strongest non-modifiable predictors — age and family history — are also missed. FINDRISC combines all of these into a single number with a clear, actionable interpretation.

What to do at each level

Score < 7 (Low): No further action indicated. Reassess in 5 years, or sooner if weight or activity changes substantially.

Score 7–11 (Slightly elevated): Lifestyle review: regular activity, vegetables daily, weight stability. Reassess in 1–3 years.

Score 12–14 (Moderate): Discuss with your GP. A fasting glucose or HbA1c test will confirm whether you already have prediabetes. Even at this band, structured lifestyle change halves your risk over 3–10 years.

Score 15–20 (High): Book a GP appointment. Indicated tests: fasting glucose, HbA1c, or 75 g OGTT. Strongly consider a structured prevention programme (in many countries this is NHS- or insurance-funded for high-risk individuals).

Score > 20 (Very high): Same — but with greater urgency. Diabetes or prediabetes is more likely already present and warrants confirmation testing within weeks, not months.

The DPS / DPP playbook

Both landmark trials reduced diabetes incidence by ~58% with the same five behavioural goals:

1. Body-weight loss of 5–7% (for participants who were overweight)
2. Physical activity ≥150 minutes/week of moderate intensity (e.g., brisk walking)
3. Dietary fibre ≥15 g per 1000 kcal — wholegrains, legumes, vegetables, fruit
4. Total fat <30% of energy
5. Saturated fat <10% of energy

The intervention was structured: brief sessions, individualised goals, regular follow-up. Self-directed lifestyle change rarely matches structured programmes — but partial adherence still produces partial benefit, which is meaningful.

Why early detection matters

Type 2 diabetes is typically asymptomatic for years before diagnosis. By the time classic symptoms (thirst, polyuria, fatigue) appear, beta-cell function is already substantially reduced. Detection and intervention during the prediabetes phase (HbA1c 5.7–6.4% / 39–47 mmol/mol) is the highest-leverage prevention window — beta cells can recover, weight loss often reverses dysglycaemia, and the natural history of the disease can genuinely be altered.

Related calculators

• BMI calculator — body-mass index with WHO bands.
• Waist-to-hip ratio calculator — sex-specific central-adiposity risk.
• BMR & TDEE calculator — daily energy needs to plan the 5–7% weight-loss target.
• Macro calculator — protein, fat, carbs structure.
• Hydration calculator — fluid needs scale with body composition.

Limitations

• Pre-existing diabetes. FINDRISC is for screening, not for people already diagnosed. If you have a known diagnosis, your management plan is set with your endocrinology / GP team.
• Pregnancy and gestational diabetes. Different screening pathways apply (OGTT at 24–28 weeks). A history of gestational diabetes substantially raises lifetime T2D risk independently of FINDRISC.
• Children and adolescents. Validated in adults only. Paediatric T2D risk uses different tools and clinical assessment.
• Type 1 diabetes. FINDRISC does not predict autoimmune diabetes (T1D), which has a different aetiology and is not preventable through lifestyle.

Privacy

All calculations run in your browser. We never see, log, or store your individual answers. Only an anonymous event (locale, risk band, sex) is sent to a privacy-respecting analytics service.